AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,472,000 | +70.2% | 185,963 | +19.9% | 0.01% | +40.0% |
| Q3 2016 | $3,803,000 | +3.6% | 155,151 | +1.1% | 0.01% | 0.0% |
| Q2 2016 | $3,671,000 | +15.0% | 153,490 | +12.5% | 0.01% | +25.0% |
| Q1 2016 | $3,191,000 | +6.6% | 136,377 | +37.5% | 0.00% | 0.0% |
| Q4 2015 | $2,993,000 | +27.4% | 99,155 | +67.6% | 0.00% | +33.3% |
| Q3 2015 | $2,350,000 | -42.5% | 59,159 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $4,086,000 | +14.7% | 59,159 | -9.2% | 0.01% | 0.0% |
| Q1 2015 | $3,562,000 | +26.2% | 65,168 | -1.6% | 0.01% | +25.0% |
| Q4 2014 | $2,823,000 | +31.7% | 66,237 | -1.4% | 0.00% | +33.3% |
| Q3 2014 | $2,144,000 | +55.5% | 67,178 | +0.9% | 0.00% | +50.0% |
| Q2 2014 | $1,379,000 | +19.1% | 66,573 | +11.3% | 0.00% | 0.0% |
| Q1 2014 | $1,158,000 | -19.5% | 59,835 | +1.0% | 0.00% | 0.0% |
| Q4 2013 | $1,438,000 | +9.7% | 59,223 | -3.0% | 0.00% | 0.0% |
| Q3 2013 | $1,311,000 | +2.2% | 61,045 | +5.9% | 0.00% | 0.0% |
| Q2 2013 | $1,283,000 | – | 57,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |